UHF Gen 2 RFID Frog 3D Tag with Secure Impinj QT™ Technology

Toronto, Canada - GAO RFID Asset Tracking (www.GAORFIDAssetTracking.com) is offering the UHF Gen 2 RFID frog 3D tag which is available in three formats: dry inlay, wet inlay and paper tag. It is widely used in RFID supply chain applications, pallet and case-level applications. This Gen 2 RFID Frog 3D tag, model 115002, uses the Impinj Monza4 IC with True3D technology for complete orientation insensitivity. It provides consistent performance on various materials and is compatible with the Impinj QT™ technology to enhance privacy security. The UHF Gen 2 tag operates over a frequency range from 860 MHz to 960 MHz. It offers EPC memory capacity up to 496 bit and user memory capacity up to 512 bit. This high performance tag is compatible with EPC Class 1 Gen 2 and ISO 18000-6C standards and allows for reliable reading even under demanding environments. This UHF Gen 2 RFID Frog 3D tag belongs to GAO's family of 865 MHz UHF RFID Tags. This line includes a wide variety of RFID tags such as UHF Gen2 DogBone RFID Tag which is a high-end RFID tag for global supply chain management and returnable transit items (RTI) and is ideally suited for pallet, case and item-level use. It also includes UHF 865 MHz Gen 2 Philips UCODE Harsh Environment RFID Tag and Passive UHF RFID Tag - Flex which has a read range over 3.5 metres and ensures accurate asset registration along with security benefits. For sales inquiries please contact: 1-877 585-9555 ext. 601 - Toll Free (USA & Canada) 1-416 292-0038 ext. 601 - All Other Areas [email protected] About GAO RFID Asset Tracking GAO RFID Asset Tracking (www.GAORFIDAssetTracking.com) is known for having one of the largest RFID tag and reader lines in the RFID product industry. GAO RFID Asset Tracking's products have been widely used in fields such as personnel access control, asset tracking, logistics and warehouse management.

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.